Paul Syribeys, MD
Plastic Surgery · Macon, GANPI 1497718258
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,146 of the $6,674 with a category attached, or 77.1%. AbbVie accounts for 76.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $2,940 and has fallen 83.4% since, to $489 in 2025.
Across 164 payments — averaging $40.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- TELA Bio, Inc.$522
- Axogen$347
- Bard Peripheral Vascular, Inc.$144
- Aroa Biosurgery Incorporated$134
- Davol Inc.$121
- plus $283 from 6 others
What the payments were for
- Travel & lodging$1,52723%
- Food & beverage$5,14677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 114 | $5,123 |
| TELA Bio, Inc. | 5 | $522 |
| Axogen | 23 | $347 |
| Bard Peripheral Vascular, Inc. | 1 | $144 |
| Aroa Biosurgery Incorporated | 3 | $134 |
| Davol Inc. | 4 | $121 |
| Polarityte, Inc. | 4 | $102 |
| Sientra, Inc. | 2 | $62 |
| Integra Lifesciences Corporation | 3 | $52 |
| Mentor Worldwide LLC | 2 | $28 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $27 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,674 in reported general payments places this provider in the 75th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Scopolamine | 13 | $210 |
| Ciprofloxacin Hcl | 28 | $176 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $162 |
| Promethazine Hcl | 20 | $40 |
| Alprazolam | 26 | $26 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Macon
- Roy PowellMacon$13K
- David ZabelAugusta$511K
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Michael McNeelMarietta$160K
- Farzad NahaiAtlanta$129K
- Michael KluskaCommerce$58K
- Sara NeimanisAtlanta$51K
- Alan LarsenAtlanta$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.